Analysis of risk factors and different treatments for infections caused by carbapenem-resistant Acinetobacter baumannii in Shaanxi, China

被引:0
|
作者
He, Xiaoliang [1 ]
Tang, Jin [1 ]
He, Sanjun [1 ]
Huang, Xiaoxia [1 ]
机构
[1] Hanzhong Cent Hosp, Dept Clin Lab, 22 Kangfu Rd, Hanzhong, Shaanxi, Peoples R China
关键词
Molecular epidemiology; Drug resistance; Mortality; Prognosis; KLEBSIELLA-PNEUMONIAE; CLINICAL ISOLATE; MORTALITY; PREDICTORS; SULBACTAM; EVOLUTION; OUTCOMES;
D O I
10.1186/s12879-024-10036-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The global threat of Carbapenem-resistant Acinetobacter baumannii (CRAB) has intensified as resistance to carbapenems continues to rise in recent decades. We aimed to explore risk factors, molecular epidemiology, and antimicrobial therapy of CRAB infection. Methods The clinical data of 110 patients infected with A. baumannii from December 2021 to December 2022 were retrospectively analyzed. Patients were divided into a carbapenem-resistance group (55 patients) and carbapenem-sensitive group (CSAB; 55 patients) based on resistance to carbapenem, and the risk factors of patients infected with CRAB were analyzed. Fifty-five patients with CRAB infection who received antimicrobial therapy were divided into a combination therapy group (45 patients) and a monotherapy group (10 patients), and differences between the two groups were compared. Whole-genome sequencing analysis was performed to assess resistance genes. Phylogenetic analysis was performed to explore the characteristics of CRAB isolates. Results Among the total 110 patients, the rate of poor prognosis in the CRAB group was 43.6% (24/55). Mechanical ventilation (odds ratio [OR] = 5.364, 95% confidence interval [CI] 1.462-19.679, P = 0.011) and puncture (OR = 19.935, 95% CI 1.261-315.031, P = 0.012) were independent risk factors for CRAB infection. Of 55 patients in the antimicrobial regimen study, 45 received combination therapy (including dual, triple, or quadruple antibiotic therapy) and 10 received monotherapy. Univariate analysis revealed significant differences between the combination group and monotherapy group for admission to the intensive care unit and wound infection (P < 0.05). The CRAB strains of 26 patients taking carbapenem-based combination therapy were mainly ST208, ST1968, and ST195, among which patients with ST1968 strains had higher 28-day mortality. Furthermore, the blaOXA-23 gene was harbored in ST1968, ST195, and ST208. Conclusions Mortality was significantly higher in patients infected with CRAB than with CSAB. Mechanical ventilation and puncture were independent risk factors in predicting CRAB infections. The distribution of CRAB was dominated by ST208, ST1968, and ST195, among which patients with ST1968 had higher 28-day mortality. The blaOXA-23 gene appears to be widely disseminated.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii
    Rossi, Iara
    Royer, Sabrina
    Ferreira, Melina Lorraine
    Campos, Paola Amaral
    Fuga, Bruna
    Melo, Gabriel Nogueira
    Machado, Luiz Gustavo
    Resende, Daiane Silva
    Batistao, Deivid
    Urzedo, Jane Eire
    Gontijo-Filho, Paulo P.
    Ribas, Rosineide Marques
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (12) : 1431 - 1435
  • [2] Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality
    Hernandez-Torres, Alicia
    Garcia-Vazquez, Elisa
    Gomez, Joaquin
    Canteras, Manuel
    Ruiz, Joaquin
    Yaguee, Genoveva
    MEDICINA CLINICA, 2012, 138 (15): : 650 - 655
  • [3] A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
    Sheng, Wang-Huei
    Liao, Chun-Hsing
    Lauderdale, Tsai-Ling
    Ko, Wen-Chien
    Chen, Yao-Shen
    Liu, Jien-Wei
    Lau, Yeu-Jun
    Wang, Li-Hsin
    Liu, Ke-Sun
    Tsai, Tung-Yuan
    Lin, San-Yi
    Hsu, Meng-Shiuan
    Hsu, Le-Yin
    Chang, Shan-Chwen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (09) : E764 - E769
  • [4] Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
    Son, Hyo-Ju
    Cho, Eun Been
    Bae, Moonsuk
    Lee, Seung Cheol
    Sung, Heungsup
    Kim, Mi-Na
    Jung, Jiwon
    Kim, Min Jae
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Woo, Jun Hee
    Kim, Yang Soo
    Chong, Yong Pil
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10):
  • [5] Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
    Liu, Chang-Pan
    Shih, Shou-Chuan
    Wang, Nai-Yu
    Wu, Alice Y.
    Sun, Fang-Ju
    Chow, Shan-Fan
    Chen, Te-Li
    Yan, Tsong-Rong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (06) : 934 - 940
  • [6] Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia
    Huang, Shih-Tse
    Chiang, Mei-Chun
    Kuo, Shu-Chen
    Lee, Yi-Tzu
    Chiang, Tong-Hong
    Yang, Su-Pen
    Ti-Yin
    Chen, Te-Li
    Fung, Chang-Phone
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (05) : 356 - 362
  • [7] Mathematical Model To Quantify the Effects of Risk Factors on Carbapenem-Resistant Acinetobacter baumannii
    Tan, Michelle W.
    Lye, David C.
    Ng, Tat-Ming
    Nikolaou, Michael
    Tam, Vincent H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5239 - 5244
  • [8] Sulbactam and Durlobactam Combination as a Newer Antibiotic for Carbapenem-Resistant Acinetobacter baumannii Infections
    Nyamagoud, Sanatkumar Bharamu
    Swamy, Agadi Hiremath Viswanatha
    Abhishek, B. J.
    Varghese, Leena Elizabeth
    Bhoomika, S. K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (02) : 289 - 298
  • [9] Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection
    Kim, Y. J.
    Kim, S. I.
    Kim, Y. R.
    Hong, K. W.
    Wie, S. H.
    Park, Y. J.
    Jeong, H.
    Kang, M. W.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (01) : 137 - 145
  • [10] The clinical features and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii infections at a tertiary hospital in Vietnam
    Diep, Duong Thi Hong
    Tuan, Huynh Minh
    Ngoc, Kha My
    Vinh, Chau
    Dung, Tran Thi Ngoc
    Phat, Voong Vinh
    Nguyen, Quynh
    Tam, Dong Thi Hoai
    Nien, Lam Vinh
    Duyen, Bui Thi Hanh
    Phung, Cao Thi
    Bac, Nguyen Hoang
    Tuan, Tran Diep
    Thwaites, Guy
    Rabaa, Maia A.
    Pham, Duy Thanh
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 33 : 267 - 275